Regeneron Logo.jpg
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of COPD with Type 2 Inflammation
23 févr. 2024 01h00 HE | Regeneron Pharmaceuticals, Inc.
Priority Review granted based on positive results from two Phase 3 trials; if approved, Dupixent would be the only biologic therapy for COPD and the first new treatment approach for this disease in...
Research Nester Logo.jpg
Endoscopy Devices Market revenue to surpass USD 52 Billion by 2036, says Research Nester
13 févr. 2024 06h30 HE | Research Nester
New York , Feb. 13, 2024 (GLOBE NEWSWIRE) -- The global endoscopy devices market size is projected to grow at a CAGR of over 5% from 2024 to 2036. The market is expected to garner a revenue of USD...
Community_Regional_Medical_Center_Vertical_RGB.jpg
Central California’s Community Regional Medical Center is the First in the State to Offer Next Generation Robotic Bronchoscopy for Early Diagnosis and Treatment of Lung Cancer
30 janv. 2024 08h00 HE | Community Regional Medical Center
Community Regional Medical Center is the First in California to Offer Next Generation Robotic Bronchoscopy for Early Diagnosis and Treatment of Lung Cancer
Blackford.png
Blackford Partners With Oxipit to Expand Chest X-Ray AI Solution Offering
22 nov. 2023 03h00 HE | Blackford
Blackford Partners With Oxipit To Expand Chest X-Ray AI Solution Offering
Polarean logo.png
Appointment of Dr. Christopher von Jako as new CEO
21 juin 2023 09h00 HE | Polarean Imaging plc
Durham, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX), the medical imaging company, announces that the Company’s Board of Directors has appointed Christopher von Jako,...
Polarean logo.png
First clinical scan using XENOVIEW conducted at Cincinnati Children’s Hospital Medical Center
11 mai 2023 10h05 HE | Polarean Imaging plc
Durham, N.C. , May 11, 2023 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM:POLX), the medical imaging company, announces that the first clinical scan utilising its XENOVIEW (xenon Xe 129...
Noah_Medical_logo_MASTER.jpg
Noah Medical Raises $150M Series B to Scale Endoluminal Robotics Solutions
19 avr. 2023 08h00 HE | Noah Medical
SAN CARLOS, Calif., April 19, 2023 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today announced that it has raised $150 million in Series B funding. With participation from a number...
Noah_Medical_logo_MASTER.jpg
Noah Medical Presents Data, Showcases the Galaxy System™ at CHEST Annual Meeting
28 oct. 2022 08h00 HE | Noah Medical
SAN CARLOS, Calif., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical provided physicians attending the American College of Chest Physicians 2022 meeting with a preview of...
Noah_Medical_logo_MASTER.jpg
Noah Medical to Showcase the Galaxy System™ at CHEST Annual Conference
06 sept. 2022 08h00 HE | Noah Medical
SAN CARLOS, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today revealed the next physician-only review and evaluation of the Galaxy System will take place from...
Noah_Medical_logo_MASTER.jpg
Noah Medical to Showcase the Galaxy System™ at AABIP Annual Meeting
08 juin 2022 08h00 HE | Noah Medical
SAN CARLOS, Calif., June 08, 2022 (GLOBE NEWSWIRE) -- Medical robotics innovator Noah Medical today revealed that the second public demonstration of its groundbreaking Galaxy System will take place...